Ali Rizvi Selected Research

dubermatinib

1/2022

AXL Inhibitor TP-0903 Reduces Metastasis and Therapy Resistance in Pancreatic Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ali Rizvi Research Topics

Disease

6	Thrombosis (Thrombus) 12/2013 - 05/2010
5	Myocardial Infarction 09/2013 - 05/2010
3	Ischemia 09/2013 - 05/2010
3	Death (Near-Death Experience) 09/2013 - 05/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2013 - 05/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 09/2013 - 05/2010
1	Immunoglobulin Light-chain Amyloidosis 07/2022
1	Adenocarcinoma 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2015
1	Atherosclerosis 01/2015
1	Hypercholesterolemia 01/2015
1	Diabetes Mellitus 12/2010
1	Type 2 Diabetes Mellitus (MODY) 01/2009
1	Myocardial Stunning (Stunned Myocardium) 01/2002

Drug/Important Bio-Agent (IBA)

2	Everolimus FDA Link 09/2013 - 05/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2013 - 05/2010
1	Congo RedIBA 07/2022
1	Coloring Agents (Dyes)IBA 07/2022
1	dubermatinibIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2015
1	LipidsIBA 01/2015
1	Lipoproteins (Lipoprotein)IBA 01/2015
1	LDL CholesterolIBA 01/2015
1	oxidized low density lipoproteinIBA 01/2015
1	omega-Chloroacetophenone (Mace)IBA 05/2012
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2009
1	Oxidants (Oxidizing Agents)IBA 01/2002

Therapy/Procedure

6	Stents 12/2013 - 05/2010
2	Percutaneous Coronary Intervention 06/2011 - 12/2010
1	Therapeutics 01/2022
1	Drug-Eluting Stents 12/2010